Long-term prognostic significance of sarcopenia in acute ischemic stroke.
Yu-Xuan Li, Juan Hou, Wen-Ya Liu
https://pubmed.ncbi.nlm.nih.gov/36042682/Actively Recruiting
Led by Centre Hospitalier Régional d'Orléans · Updated on 2026-02-02
250
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the role of body composition in predicting recovery outcomes for patients who have suffered an acute stroke. This research aims to determine whether measures like skeletal muscle index, phase angle from bioimpedance analysis, and temporal muscle size can forecast patients functional abilities at hospital discharge and six months later. The study focuses on how premorbid muscle mass and strength relate to stroke recovery, seeking to improve rehabilitation planning and care decisions. The study involves measuring body composition using bioimpedance meters to assess skeletal muscle index and phase angle, along with ultrasound measurements of temporal muscle thickness and surface area within 72 hours after stroke onset. Researchers will also collect clinical data such as weight, height, initial stroke deficit, and lesion volume. Participants will be evaluated with the Modified Rankin Scale to assess their functional status at discharge and during follow-up visits at three and six months. Participants will undergo body composition and muscle measurements soon after their stroke. Their functional outcomes will be tracked using standardized scales over time. The main focus is on correlating early body composition markers with recovery levels at discharge and six months. This approach may help identify patients at higher risk of poor functional recovery and guide personalized rehabilitation strategies. The study duration spans from initial hospitalization through at least six months of follow-up.
CONDITIONS
Body Composition and Acute Stroke
M
Marc VERIN, PUPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Centre Hospitalier Régional d'Orléans
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Within 72 hours after stroke
Participants undergo body composition measurements using bioimpedance and temporal muscle assessment within 72 hours after stroke.
1 visit (in-person)
Duration - Up to 6 months
Participants are monitored for functional outcomes using the modified Rankin Scale at discharge and up to 6 months after the stroke.
Follow-up visits at discharge and Month 6
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Yu-Xuan Li, Juan Hou, Wen-Ya Liu
https://pubmed.ncbi.nlm.nih.gov/36042682/Masafumi Nozoe, Hiroki Kubo, Masashi Kanai...
https://pubmed.ncbi.nlm.nih.gov/33395619/Daniel Dubinski, Sae-Yeon Won, Isabell Mattes...
https://pubmed.ncbi.nlm.nih.gov/37822528/A Amir, Z Pittel, A Shahar...
https://pubmed.ncbi.nlm.nih.gov/3409012/Masahito Katsuki, Yukinari Kakizawa, Akihiro Nishikawa...
https://pubmed.ncbi.nlm.nih.gov/35277046/Ayano Nagano, Akio Shimizu, Keisuke Maeda...
https://pubmed.ncbi.nlm.nih.gov/36501078/Ho-Geon Namgung, Seungho Hong, Young-Ah Choi
https://pubmed.ncbi.nlm.nih.gov/37373767/Centre Hospitalier Régional d'Orléans
Lead Sponsor